PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Glycoproteins (Glycoprotein)

Subscribe to Selected New Research on Glycoproteins

14707 relevant articles (365 outcomes, 1243 trials/studies) found for this Bio-Agent

Description: Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.

Also Known As:

Glycoprotein; Neoglycoproteins

Relationship Network

Bio-Agent Context: Research Results

-

Carbohydrates: 2945

-

Glycoconjugates: 587

-

Glycoproteins: 14707

*

Cholesterol Ester Transfer Proteins: 303

*

urinastatin: 268

*

tumor-associated antigen 72: 252

*

trabecular meshwork-induced glucocorticoid response protein: 227

*

calpain inhibitors: 201

*

amphiregulin: 198

*

cartilage matrix protein: 182

*

tissue-factor-pathway inhibitor 2: 127

*

FRZB protein: 83

*

trans-sialidase: 66

*

milk fat globule: 54

*

gastric mucus glycoproteins: 50

*

teleocalcin: 41

*

amyloid enhancing factor: 35

*

AC133 antigen: 33

*

Bos taurus structural-GP protein: 28

*

*

nephrocalcin: 18

*

olfactomedin: 18

*

*

CD52 antigen: 16

*

nephritogenoside: 16

*

placental protein 10: 16

*

glycosylated serum protein: 14

*

human CHI3L1 protein: 14

*

*

glycoprotein CX 1: 12

*

beta-glucuronidase inhibitor: 11

*

lysolecithin acylhydrolase: 11

*

purple acid phosphatase: 11

*

glucose-regulated protein 170: 10

*

fucoproteins: 9

*

*

*

equine infectious anemia virus SU protein: 6

*

myelin oligodendrocyte glycoprotein (35-55): 6

*

*

glycoprotein GP51: 5

*

placental protein 19: 5

*

Rabies virus glycoprotein G: 5

*

ADAM Proteins: 4

*

restrictin-P: 4

*

Echinococcus granulosus antigen 5: 3

*

Felis domesticus Fel d 1 protein: 3

*

glycoprotein BCA 225: 3

*

rat macrocortin protein: 3

*

thyrostimulin: 3

*

acid labile subunit insulin-like growth factor binding protein: 2

*

*

embryonic prealbumin: 2

*

*

*

gonadotropin inhibitor: 2

*

LCAP lung cancer-associated protein: 2

*

neurexophilin: 2

*

OVX1 antigen: 2

*

*

uterine luminal fluid proteins: 2

*

*

aplysianin A: 1

*

*

Dolabella auricularia dolabellanin A protein: 1

*

Dollabella auricularia dolabellanin C protein: 1

*

galactoproteins: 1

*

glycoprotein GP 68: 1

*

human chondronectin protein: 1

*

human factor J protein: 1

*

*

*

peptido-rhamnomannan: 1

*

protein M (glycoprotein): 1

*

ramoplanin A2: 1

*

recombinant HAR-TX beta 2 protein: 1

*

toposome glycoprotein complex: 1

*

140-kDa epididymal secretory glycoprotein

*

86-kDa gynecophoral canal protein

*

Ajellomyces capsulatus M antigen

*

Ala(37)- myelin oligodendrocyte glycoprotein (35-50)

*

albumin-binding protein gp18

*

albumin-binding protein gp30

*

Amaranthus leucocarpus lectin

*

Anastrepha suspensa parasitism-specific protein

*

Anastrepha suspensa PSG4 protein

*

Anastrepha suspensa PSG8 protein

*

Ancylostoma caninum NIF protein

*

Antirrhinum majus PTL1 protein

*

Apis mellifera MRJP3 protein

*

Aplysia attractin protein

*

Arabidopsis AERO1 protein

*

Arabidopsis AtGer2 protein

*

Arabidopsis RGP1 protein

*

Arabidopsis RSH protein

*

Arachis hypogaea Ara h 1 protein

*

Arachis hypogaea Ara h 2 allergen

*

Arachis hypogaea Ara h 4 allergen

*

Arachis hypogaea Ara h II protein

*

Artemia artemocyanin protein

*

Artemisia vulgaris L. allergen Art v II protein

*

Aspergillus fumigatus gp55 protein

*

Aspergillus nidulans ASPND1 protein

-

Amino Acids, Peptides, and Proteins

-

Proteins: 58433

-

Glycoproteins: 14707

*

Tumor Necrosis Factor-alpha: 35484

*

Protein C: 3385

*

Proteoglycans: 2627

*

Thyroglobulin: 2560

*

Membrane Glycoproteins: 1543

*

Protein S: 1492

*

*

Lactoferrin: 1180

*

Colony-Stimulating Factors: 1016

*

*

Thrombopoietin: 596

*

beta 2-Glycoprotein I: 474

*

Vitronectin: 431

*

*

*

alpha 1-Antichymotrypsin: 347

*

Cholesterol Ester Transfer Proteins: 303

*

urinastatin: 268

*

tumor-associated antigen 72: 252

*

Thyroxine-Binding Proteins: 232

*

trabecular meshwork-induced glucocorticoid response protein: 227

*

calpain inhibitors: 201

*

amphiregulin: 198

*

Transcortin: 196

*

Mucoproteins: 191

*

Serum Amyloid P-Component: 184

*

cartilage matrix protein: 182

*

B-Cell Activating Factor: 174

*

Osteonectin: 164

*

*

tissue-factor-pathway inhibitor 2: 127

*

Myelin P0 Protein: 125

*

FRZB protein: 83

*

Sialoglycoproteins: 82

*

Uteroglobin: 77

*

trans-sialidase: 66

*

milk fat globule: 54

*

gastric mucus glycoproteins: 50

*

4-1BB Ligand: 41

*

teleocalcin: 41

*

amyloid enhancing factor: 35

*

AC133 antigen: 33

*

Asialoglycoproteins: 28

*

Bos taurus structural-GP protein: 28

*

*

nephrocalcin: 18

*

olfactomedin: 18

*

*

CD52 antigen: 16

*

nephritogenoside: 16

*

placental protein 10: 16

*

glycosylated serum protein: 14

*

human CHI3L1 protein: 14

*

*

CD70 Antigens: 12

*

glycoprotein CX 1: 12

*

beta-glucuronidase inhibitor: 11

*

lysolecithin acylhydrolase: 11

*

purple acid phosphatase: 11

*

glucose-regulated protein 170: 10

*

fucoproteins: 9

*

*

*

equine infectious anemia virus SU protein: 6

*

myelin oligodendrocyte glycoprotein (35-55): 6

*

*

glycoprotein GP51: 5

*

placental protein 19: 5

*

Rabies virus glycoprotein G: 5

*

ADAM Proteins: 4

*

restrictin-P: 4

*

Echinococcus granulosus antigen 5: 3

*

Felis domesticus Fel d 1 protein: 3

*

glycoprotein BCA 225: 3

*

rat macrocortin protein: 3

*

thyrostimulin: 3

*

acid labile subunit insulin-like growth factor binding protein: 2

*

*

embryonic prealbumin: 2

*

*

*

gonadotropin inhibitor: 2

*

LCAP lung cancer-associated protein: 2

*

neurexophilin: 2

*

OVX1 antigen: 2

*

*

uterine luminal fluid proteins: 2

*

*

aplysianin A: 1

*

*

Dolabella auricularia dolabellanin A protein: 1

*

Dollabella auricularia dolabellanin C protein: 1

*

galactoproteins: 1

*

glycoprotein GP 68: 1

*

human chondronectin protein: 1

*

human factor J protein: 1

*

*

*

peptido-rhamnomannan: 1

*

protein M (glycoprotein): 1

Experts

1.	Topol, E J: 21 articles (10/2003 - 01/2000)
2.	Califf, R M: 17 articles (10/2003 - 01/2000)
3.	Harrington, Robert A: 16 articles (05/2007 - 01/2002)
4.	Lincoff, A M: 14 articles (10/2003 - 02/2000)
5.	Topol, Eric J: 13 articles (05/2005 - 01/2002)
6.	Simoons, M L: 13 articles (01/2003 - 01/2000)
7.	Califf, Robert M: 12 articles (04/2007 - 01/2002)
8.	Harrington, R A: 12 articles (02/2002 - 01/2000)
9.	Moliterno, David J: 10 articles (04/2007 - 01/2002)
10.	Boersma, Eric: 10 articles (04/2007 - 01/2002)

Related Diseases

1.

08/01/1997 - "A trial vaccine containing pseudorabies virus (PRV) glycoprotein gC as the main component showed excellent protection against virulent virus infection in pigs. "
06/01/1990 - "Antibody mediated and cell mediated immune responses to the envelope glycoproteins gp120 and gp41 of the human immunodeficiency virus (HIV-1) are considered important for protection against infection and for attenuation of disease symptoms after infection. "
12/15/2005 - "In recent clinical trials, a vaccine that contained herpes simplex virus type 2 (HSV-2) glycoprotein D (gD2) and the adjuvant AS04 afforded HSV-seronegative women significant protection against HSV-2 genital disease and limited protection against infection. "
11/01/2008 - "colubriformis glycoprotein Tc-120 and CarLA were tested in the passive immunity model and it was found that only the antibody against CarLA resulted in a significant reduction of infection (87%). "
08/01/2008 - "Because direct immunization of the respiratory tract should be particularly effective against infection of mucosal surfaces, we previously developed an intranasal vaccine based on replication-competent human parainfluenza virus type 3 (HPIV3) expressing EBOV glycoprotein GP (HPIV3/EboGP) and showed that it is immunogenic and protective against a high dose parenteral EBOV challenge. "
Order ALL the reference details at left...

2.

Myocardial Infarction

04/01/2009 - "Several clinical trials have shown that antagonists of the glycoprotein IIb/IIIa receptor decreased the incidence of death, nonfatal myocardial infarction, and the need for urgent revascularization when administered immediately before or during the 24- to 48-hour period aft